Literature DB >> 2714893

Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines.

M Rotheneder1, G M Kostner.   

Abstract

The influence of low- and high-density lipoproteins on the proliferation of human breast cancer cells in culture was studied. We compared total cell number after incubation for 48 hr in culture medium containing or lacking plasma lipoproteins. Marked differences were found between hormone-dependent (MCF-7, T-47-D, ZR-75) and hormone-independent (MDA-MB-231, HBL-100) mammary tumor cell lines. The cells also reacted differently on the different lipoproteins offered in the medium. Human low-density lipoproteins (LDL) exhibited a marked stimulation of the growth of hormone-independent cell lines but no or only toxic effects upon the hormone-sensitive lines. Human high-density lipoproteins (HDL) stimulated the proliferation of all cell lines in a dose-dependent manner but hormone-independent cells showed a higher response. These findings point towards different utilizations of nutrients in hormone-dependent and hormone-independent cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714893     DOI: 10.1002/ijc.2910430523

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.

Authors:  Lisa J Martin; Olga Melnichouk; Ella Huszti; Philip W Connelly; Carolyn V Greenberg; Salomon Minkin; Norman F Boyd
Journal:  J Natl Cancer Inst       Date:  2015-03-28       Impact factor: 13.506

Review 2.  Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

Authors:  Kaylin M McMahon; Linda Foit; Nicholas L Angeloni; Francis J Giles; Leo I Gordon; C Shad Thaxton
Journal:  Cancer Treat Res       Date:  2015

3.  Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification.

Authors:  Caryl J Antalis; Aki Uchida; Kimberly K Buhman; Rafat A Siddiqui
Journal:  Clin Exp Metastasis       Date:  2011-07-09       Impact factor: 5.150

4.  The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake.

Authors:  P J Pussinen; B Karten; A Wintersperger; H Reicher; M McLean; E Malle; W Sattler
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

5.  Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

Authors:  Dunja Sobot; Simona Mura; Marie Rouquette; Branko Vukosavljevic; Fanny Cayre; Eric Buchy; Grégory Pieters; Sébastien Garcia-Argote; Maike Windbergs; Didier Desmaële; Patrick Couvreur
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

Review 6.  Synthetic high-density lipoprotein-like nanoparticles for cancer therapy.

Authors:  Linda Foit; Francis J Giles; Leo I Gordon; Colby Shad Thaxton
Journal:  Expert Rev Anticancer Ther       Date:  2014-12-09       Impact factor: 4.512

7.  Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E.

Authors:  V Chajès; W Sattler; A Stranzl; G M Kostner
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

8.  Regulation of cholesterol synthesis in four colonic adenocarcinoma cell lines.

Authors:  S R Cerda; J Wilkinson; S A Broitman
Journal:  Lipids       Date:  1995-12       Impact factor: 1.880

9.  A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.

Authors:  Alicia Beeghly-Fadiel; Nikhil K Khankari; Ryan J Delahanty; Xiao-Ou Shu; Yingchang Lu; Marjanka K Schmidt; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Joe Dennis; Drakoulis Yannoukakos; Alison M Dunning; Paul D P Pharoah; Georgia Chenevix-Trench; Roger L Milne; David J Hunter; Hall Per; Peter Kraft; Jacques Simard; Douglas F Easton; Wei Zheng
Journal:  Int J Epidemiol       Date:  2020-08-01       Impact factor: 7.196

10.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.